Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Thursday, June 30, 2022

Lucintel Forecasts Hospital Acquired Disease Testing Market to Grow at a CAGR of 14%-16% from 2020 to 2025

According to the recent study the Hospital Acquired Disease Testing Market is projected to grow at a CAGR of 14%-16% from 2020 to 2025. Growth in this market is primarily driven by increasing prevalence of hospital acquired infections, growing number of drug-resistant pathogens, and rising awareness among people of hospital acquired diseases.

Browse XX figures / charts and XX tables in this 150 -page report to understand trends, opportunities and forecast in hospital acquired disease testing market by test type (urinary tract infection, surgical site infection, pneumonia stents, blood stream infection, and methicillin-resistant staphylococcus aureus), end user (hospitals and intensive care units (ICUs), ambulatory surgical and diagnostic centers, and nursing homes and maternity centers), and region (North America, Europe, Asia Pacific, and Rest of the World).

Download sample report and view detailed Table of Content by clicking on below link https://www.lucintel.com/hospital-acquired-disease-testing-market.aspx

“Urinary tract infection market is expected to remain the largest segment during the forecast period.”

Based on test type, the hospital acquired disease testing market is segmented into urinary tract infection, surgical site infection, pneumonia stents, blood stream infection, and methicillin-resistant staphylococcus aureus. Lucintel forecasts that the urinary tract infection market is expected to remain the largest segment due to high prevalence of hospital acquired infections and increasingly popular techniques that are being used for preventing, diagnosing, & treating the hospital-associated infections, such as polymerise chain reaction (PCR), solid-phase hybridization, and microarrays.

“Within the hospital acquired disease testing market, the hospitals and intensive care units (ICUs) segment is expected to remain the largest end user.”

Based on end user the hospitals and intensive care units (ICUs) segment is expected to witness the highest growth over the forecast period.

“North America will dominate the hospital acquired disease testing market in near future.”

North America will remain the largest region over the forecast period due to increase in geriatric population and robust healthcare infrastructure in this region.

Download Brochure of this report by clicking on https://www.lucintel.com/hospital-acquired-disease-testing-market.aspx

Major players of hospital acquired disease testing market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Diatherix Corp, Roche, Cantel Medical Corporation, Qiagen, and Cephid, bioMeriux are among the major hospital acquired disease testing providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/hospital-acquired-disease-testing-market.aspx  or helpdesk@lucintel.com.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com.

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email:
brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751

Related reports

Healthcare IT Market:

For more details click here https://www.lucintel.com/healthcare-it-market.aspx

 

Medical Holography Market:

For more details click here https://www.lucintel.com/medical-holography-market.aspx

 

Minimally Invasive Surgical Instrument Market:

For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx

 

Endoscopy Equipment Market:

For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx

 

Surgical Instrument Tracking System Market:

For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

 

Metabolomics Market:

For more details click here https://www.lucintel.com/metabolomics-market.aspx

 

Industrial Microbiology Market:

For more details click here https://www.lucintel.com/opportunities-in-the-industrial-microbiologycolonopt-size,-trends-and-growth-analysis.aspx

 

Surgical Microscope Market:

For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

 

Tumor Ablation Market:

For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

 

Vitamin D Market:

For more details click here https://www.lucintel.com/vitamin-d-market.aspx

No comments:

Post a Comment